Navigation Links
Global Transdermal Drug Delivery Market 2014-2018: Key Vendors are ANI Pharmaceuticals, Antares Pharma, Bayer, Janssen and Novartis
Date:8/7/2014

DUBLIN, Aug. 7, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Transdermal Drug Delivery Market 2014-2018" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

Transdermal drug delivery is a large and growing vertical market of the Pharmaceutical industry. Transdermal drug delivery is defined as a system that utilizes skin as a site for continuous drug administration into the systemic circulation. Several methods of transdermal drug delivery include plasters, various ointments and, most commonly, patches. Transdermal drug administration has several advantages.

First, the method of delivery is non-invasive, which is much less traumatic to the patient as compared to other forms of drug delivery. Also, it can be effective in assuring that a patient receives a full dosage of a drug and helps in increasing the compliance rate. However, there are difficulties associated with administering medication through the skin. The natural function of the skin is to act as a protective barrier, so it is often the case that drugs are not chemically suitable to penetrating the skin.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Competitive Assessment of Transdermal Drugs Delivery Market

08. Optimisation of Transdermal Drug Delivery

09. Market Segmentation by Application

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Key Vendor Analysis

20. Other Reports in this Series

Companies Mentioned:

  • ANI Pharmaceuticals Inc.
  • Antares Pharma Inc.
  • Bayer AG
  • Janssen Pharmaceuticals Inc.
  • Novartis AG
  • 3M Pharmaceuticals Co.
  • Durect Corp.
  • Iontera Inc.
  • Isis Biopolymer Inc.
  • LTS Lohmann Therapie-Systeme AG
  • Mylan Laboratories Inc.
  • Nitto Denko Corp.
  • Pantec Biosolutions AG
  • Phosphagenics Ltd.
  • Tesa Labtec GmbH
  • Teva Pharmaceutical Industries Ltd.

For more information visit http://www.researchandmarkets.com/research/dj2pc6/global

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Hemoglobin A1c Testing Devices (Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay) Market - Forecast to 2019
2. Global Safety Syringes (Automatic Retractable Safety Syringes, Manual Retractable Safety Syringes, Non-Retractable Safety Syringes) Market - Forecast to 2019
3. Enteral Feeding Devices Market (Enteral Feeding Tubes, Enteral Feeding Pumps, Administration Reservoir, Giving Sets and Enteral Syringes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
4. Orthopedic Soft Tissue Repair Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
5. Antibacterial Drugs Market (By Class and Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
6. Global Digital X-ray (Floor to ceiling mounted, Ceiling mounted, Handheld) Market - Forecast to 2018
7. Global Patient Safety Highlighted by NABP, Domestic and International Stakeholders at .Pharmacy Supporter Advisory Committee Meeting
8. Myalgia Global Clinical Trials Review, H2, 2014
9. Myoclonus Global Clinical Trials Review, H2, 2014
10. Neuralgia Global Clinical Trials Review, H2, 2014
11. Multiple Sclerosis Global Clinical Trials Review, H2, 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... 10, 2017 Radiology has become the number ... have also spiraled to the number one ranking as ... than ever before as the most complete and reliable ... with lower back pain an MRI may confirm a ... pain, resulting in entirely different treatment protocols.  In these ...
(Date:5/9/2017)...  Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... focused on the development of oral drug delivery ... Office has granted Oramed a patent titled, "Methods ... patent covers Oramed,s invention of an oral glucagon-like ... incretin hormone that stimulates the secretion of insulin ...
(Date:5/6/2017)... , May 5, 2017   Provista , a proven ... than 200,000 customers, today announced Jim Cunniff as ... of executive and business experience to Provista, including most recently ... in California . He assumed his new ... is a great fit for Provista," says Jody Hatcher ...
Breaking Medicine Technology:
(Date:5/28/2017)... ... 2017 , ... Viewers likely know Rob Lowe from such 80s hits as ... his work on NBC’s The West Wing and Parks and Recreation. But recently, Lowe’s ... which puts the spotlight on important modern-day issues that face today’s society. One of ...
(Date:5/27/2017)... ... May 27, 2017 , ... In any business, follow up is critical to ... dental team at presenting treatment, there will always be some patients who can’t or ... money on best practices when it comes to presenting treatment. After the patient ...
(Date:5/26/2017)... ... May 26, 2017 , ... Mediaplanet is proud to announce the launch of ... which will educate readers on how to take care of all aspects of their ... placed on melanoma. Dancing with the Stars professional, Witney Carson, shares her journey with ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... new educational seminar to focus on current legislative activity and the latest regulatory ... at 1 p.m. Sunday, Sept. 10, and will continue through Monday, Sept. 11, ...
(Date:5/26/2017)... ... May 26, 2017 , ... A new analysis of community health data ... are located in the Midwest. With the average cost of healthcare rising and the ... with both the quality and affordability of where they live. An annual 2017 report ...
Breaking Medicine News(10 mins):